These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 26148238)
1. RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition. Bousquet E; Calvayrac O; Mazières J; Lajoie-Mazenc I; Boubekeur N; Favre G; Pradines A Oncogene; 2016 Apr; 35(14):1760-9. PubMed ID: 26148238 [TBL] [Abstract][Full Text] [Related]
2. RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers. Calvayrac O; Pradines A; Favre G Small GTPases; 2018 Jul; 9(4):339-344. PubMed ID: 27676292 [TBL] [Abstract][Full Text] [Related]
3. RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway. Dubois F; Keller M; Calvayrac O; Soncin F; Hoa L; Hergovich A; Parrini MC; Mazières J; Vaisse-Lesteven M; Camonis J; Levallet G; Zalcman G Cancer Res; 2016 Mar; 76(6):1627-40. PubMed ID: 26759237 [TBL] [Abstract][Full Text] [Related]
4. miR-19a-mediated downregulation of RhoB inhibits the dephosphorylation of AKT1 and induces osteosarcoma cell metastasis. Zou Q; Xiao X; Liang Y; Peng L; Guo Z; Li W; Yu W Cancer Lett; 2018 Aug; 428():147-159. PubMed ID: 29702193 [TBL] [Abstract][Full Text] [Related]
5. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Sato N; Fukui T; Taniguchi T; Yokoyama T; Kondo M; Nagasaka T; Goto Y; Gao W; Ueda Y; Yokoi K; Minna JD; Osada H; Kondo Y; Sekido Y Int J Cancer; 2007 Feb; 120(3):543-51. PubMed ID: 17096327 [TBL] [Abstract][Full Text] [Related]
6. PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer. Singh D; Qiu Z; Jonathan SM; Fa P; Thomas H; Prasad CB; Cai S; Wang JJ; Yan C; Zhang X; Venere M; Li Z; Sizemore ST; Wang QE; Zhang J Cancer Lett; 2024 Aug; 598():217110. PubMed ID: 38986733 [TBL] [Abstract][Full Text] [Related]
7. Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1. Bousquet E; Mazières J; Privat M; Rizzati V; Casanova A; Ledoux A; Mery E; Couderc B; Favre G; Pradines A Cancer Res; 2009 Aug; 69(15):6092-9. PubMed ID: 19602596 [TBL] [Abstract][Full Text] [Related]
8. miR-19a promotes invasion and epithelial to mesenchymal transition of bladder cancer cells by targeting RhoB. Li Z; Li Y; Wang Y J BUON; 2019; 24(2):797-804. PubMed ID: 31128038 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells. Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC). Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823 [TBL] [Abstract][Full Text] [Related]
11. NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells. Keller M; Dubois F; Teulier S; Martin APJ; Levallet J; Maille E; Brosseau S; Elie N; Hergovich A; Bergot E; Camonis J; Zalcman G; Levallet G J Exp Clin Cancer Res; 2019 Apr; 38(1):158. PubMed ID: 30979377 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Wang S; Yan-Neale Y; Fischer D; Zeremski M; Cai R; Zhu J; Asselbergs F; Hampton G; Cohen D Oncogene; 2003 Sep; 22(40):6204-13. PubMed ID: 13679859 [TBL] [Abstract][Full Text] [Related]
14. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Ho HH; Chang CS; Ho WC; Liao SY; Lin WL; Wang CJ Toxicol Appl Pharmacol; 2013 Jan; 266(1):76-85. PubMed ID: 23153558 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of RhoB loss of expression in lung cancer. Mazières J; Tovar D; He B; Nieto-Acosta J; Marty-Detraves C; Clanet C; Pradines A; Jablons D; Favre G BMC Cancer; 2007 Nov; 7():220. PubMed ID: 18047684 [TBL] [Abstract][Full Text] [Related]
16. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Jiang K; Sun J; Cheng J; Djeu JY; Wei S; Sebti S Mol Cell Biol; 2004 Jun; 24(12):5565-76. PubMed ID: 15169915 [TBL] [Abstract][Full Text] [Related]
17. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
18. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation. Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the small GTPase RhoB gene by TGF{beta}-induced signaling pathways. Vasilaki E; Papadimitriou E; Tajadura V; Ridley AJ; Stournaras C; Kardassis D FASEB J; 2010 Mar; 24(3):891-905. PubMed ID: 19890017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]